Autism Society records most keynote and concurrent sessions at their annual conferences. You can see and hear those recordings by purchasing full online access, or individual recordings.
Although genetics undoubtedly plays a significant role, that role may in many cases contribute to increasing vulnerability to environmental factors rather than leading inevitably to the developmental condition. One active area of research focuses on the way that genetic vulnerability and environmental factors interact to lead to altered development. The study of gene-environment interactions, and the role environmental factors might play in leading to developmental disorders, is just beginning. No single environmental agent has been implicated as a unique cause of these disorders; furthermore, investigations of most environmental agents are hampered by the absence of neurodevelopmental toxicity data for most industrial chemicals in widespread use, even when population-wide exposures are documented to be on the rise.
Despite these data gaps, many environmental agents are known to alter brain development as well as function, and may lead to oxidative stress, inflammation, and other metabolic changes increasingly documented in autism and other developmental conditions. In addition, such chronic metabolic changes are being identified not only in the brain but also in other organs of the body, particularly the gastrointestinal and the immune systems, body tissues that are particularly vulnerable to environmental influences.
If the environment plays a role in the production of developmental disorders, identification of the mechanisms by which environmental factors may lead to these changes may also help us discover ways to treat these problems, thereby improving the level of functioning of affected individuals. The study of gene-environment interactions and of environmental influences in developmental disorders will also yield opportunities for understanding the causes and nature of developmental disorders, and which individuals may be at risk. Finally, if there are avoidable causes of or contributors to developmental disorders, identifying them will permit us to develop strategies to prevent exposures to such factors in the future. Reducing exposure to risky and dangerous environmental agents will be a service to future generations. Identifying ways of treating these disorders based on an understanding of gene-environment interactions has the potential to increase the number of treatments available to children affected now.
Learning objectives for this session will include the following:
1. Attendees will learn about evidence relating to the numbers of affected individuals and whether these numbers have changed over time.
2. Attendees will learn about the ways in which environmental factors can alter brain development and function.
3. Attendees will learn how genes may alter the vulnerability of an individual to certain environmental factors, rendering some individuals susceptible, and others relatively resistant, to the development of brain disorders after early life exposures.
4. Attendees will learn how delineating the mechanisms by which environmental factors affect development and function will promote discovery of new treatment strategies capable of improving the level of functioning amongst affected individuals.
Content Area: Medicine and Research
Martha Herbert, MD, PhD
Pediatric Neurologist
Massachusetts General Hospital,
Mady Hornig, MD, MA
Associate Professor of Epidemiology and Director of Translational Research
Columbia University
Ted Schettler, MD, MPH
Science Director
Science and Environmental Health Network